麻醉疼痛科指南

订阅

MedSci主页 / 所有栏目 / 麻醉疼痛科指南

2020 SNACC指南：卒中高危患者在非心脏，非神经科手术期间或之后围术期管理

2020-05-18 神经麻醉与重症监护学会 J Neurosurg Anesthesiol . 2020 May 18.

卒中围术期

2020年5月，神经麻醉与重症监护学会(SNACC)发布了卒中高危患者在非心脏，非神经科手术期间或之后围术期管理指南，围手术期卒中发病率和死亡率值得重视，卒中的识别和诊断在围手术期充满挑战，本文主要针

中文标题：

2020 SNACC指南：卒中高危患者在非心脏，非神经科手术期间或之后围术期管理

英文标题：

Perioperative Care of Patients at High Risk for Stroke During or After Non-Cardiac, Non-Neurological Surgery: 2020 Guidelines From the Society for Neuroscience in Anesthesiology and Critical Care

发布机构：

神经麻醉与重症监护学会

发布日期：

2020-05-18

简要介绍：

2020年5月，神经麻醉与重症监护学会(SNACC)发布了卒中高危患者在非心脏，非神经科手术期间或之后围术期管理指南，围手术期卒中发病率和死亡率值得重视，卒中的识别和诊断在围手术期充满挑战，本文主要针对卒中高危患者在非心脏，非神经科手术期间或之后围术期管理提供指导建议。

 

相关资料下载：
[AttachmentFileName(sort=1, fileName=2020 SNACC指南：卒中高危患者在非心脏，非神经科手术期间或之后围术期管理.pdf)] GetToolGuiderByIdResponse(projectId=1, id=35f5f1c001908e27, title=2020 SNACC指南：卒中高危患者在非心脏，非神经科手术期间或之后围术期管理, enTitle=Perioperative Care of Patients at High Risk for Stroke During or After Non-Cardiac, Non-Neurological Surgery: 2020 Guidelines From the Society for Neuroscience in Anesthesiology and Critical Care, guiderFrom=J Neurosurg Anesthesiol . 2020 May 18., authorId=0, author=, summary=2020年5月，神经麻醉与重症监护学会(SNACC)发布了卒中高危患者在非心脏，非神经科手术期间或之后围术期管理指南，围手术期卒中发病率和死亡率值得重视，卒中的识别和诊断在围手术期充满挑战，本文主要针, cover=https://img.medsci.cn/2020523/1590245890238_2020535.jpg, journalId=0, articlesId=null, associationId=1001, associationName=神经麻醉与重症监护学会, associationIntro=null, copyright=0, guiderPublishedTime=Mon May 18 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2020年5月，神经麻醉与重症监护学会(SNACC)发布了卒中高危患者在非心脏，非神经科手术期间或之后围术期管理指南，围手术期卒中发病率和死亡率值得重视，卒中的识别和诊断在围手术期充满挑战，本文主要针对卒中高危患者在非心脏，非神经科手术期间或之后围术期管理提供指导建议。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=365, tagName=卒中), TagDto(tagId=12840, tagName=围术期)], categoryList=[CategoryDto(categoryId=29, categoryName=麻醉疼痛科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=12840, guiderKeyword=围术期, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5206, appHits=165, showAppHits=123, pcHits=1397, showPcHits=5285, likes=1, shares=13, comments=4, approvalStatus=1, publishedTime=Sat May 23 23:24:16 CST 2020, publishedTimeString=2020-05-18, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sat May 23 22:58:27 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Fri Jan 05 11:27:44 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 SNACC指南：卒中高危患者在非心脏，非神经科手术期间或之后围术期管理.pdf)])
2020 SNACC指南：卒中高危患者在非心脏，非神经科手术期间或之后围术期管理.pdf
下载请点击：
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1226836, encodeId=783c122683600, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fc91767151, createdName=刘妍, createdTime=Thu Jun 16 16:11:08 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956507, encodeId=3f3695650e0b, content=正想学习这个, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78f92247333, createdName=12159132m27(暂无昵称), createdTime=Tue Apr 13 11:16:28 CST 2021, time=2021-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921846, encodeId=814792184604, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=127c5457677, createdName=ms9000000172634018, createdTime=Mon Feb 01 09:35:11 CST 2021, time=2021-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921808, encodeId=771692180841, content=非常有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c7aa5453124, createdName=nvc0520, createdTime=Mon Feb 01 02:23:47 CST 2021, time=2021-02-01, status=1, ipAttribution=)]
    2022-06-16 刘妍

    感谢

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1226836, encodeId=783c122683600, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fc91767151, createdName=刘妍, createdTime=Thu Jun 16 16:11:08 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956507, encodeId=3f3695650e0b, content=正想学习这个, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78f92247333, createdName=12159132m27(暂无昵称), createdTime=Tue Apr 13 11:16:28 CST 2021, time=2021-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921846, encodeId=814792184604, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=127c5457677, createdName=ms9000000172634018, createdTime=Mon Feb 01 09:35:11 CST 2021, time=2021-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921808, encodeId=771692180841, content=非常有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c7aa5453124, createdName=nvc0520, createdTime=Mon Feb 01 02:23:47 CST 2021, time=2021-02-01, status=1, ipAttribution=)]
    2021-04-13 12159132m27(暂无昵称)

    正想学习这个

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1226836, encodeId=783c122683600, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fc91767151, createdName=刘妍, createdTime=Thu Jun 16 16:11:08 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956507, encodeId=3f3695650e0b, content=正想学习这个, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78f92247333, createdName=12159132m27(暂无昵称), createdTime=Tue Apr 13 11:16:28 CST 2021, time=2021-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921846, encodeId=814792184604, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=127c5457677, createdName=ms9000000172634018, createdTime=Mon Feb 01 09:35:11 CST 2021, time=2021-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921808, encodeId=771692180841, content=非常有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c7aa5453124, createdName=nvc0520, createdTime=Mon Feb 01 02:23:47 CST 2021, time=2021-02-01, status=1, ipAttribution=)]
    2021-02-01 ms9000000172634018

    感谢

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1226836, encodeId=783c122683600, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fc91767151, createdName=刘妍, createdTime=Thu Jun 16 16:11:08 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956507, encodeId=3f3695650e0b, content=正想学习这个, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78f92247333, createdName=12159132m27(暂无昵称), createdTime=Tue Apr 13 11:16:28 CST 2021, time=2021-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921846, encodeId=814792184604, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=127c5457677, createdName=ms9000000172634018, createdTime=Mon Feb 01 09:35:11 CST 2021, time=2021-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921808, encodeId=771692180841, content=非常有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c7aa5453124, createdName=nvc0520, createdTime=Mon Feb 01 02:23:47 CST 2021, time=2021-02-01, status=1, ipAttribution=)]
    2021-02-01 nvc0520

    非常有用

    0

相关指南

2020 EAN/ERS/ESO/ESRS声明：睡眠障碍对卒中风险和结局的影响

欧洲神经病学研究院(EAN,European Academy of Neurology) · 2020-04-20

2019 加拿大卒中最佳实践建议：卒中后康复，恢复和社区参与-part2

加拿大心脏与卒中基金会(HSFC,Heart and Stroke Foundation of Canada) · 2020-01-27

2019 加拿大卒中最佳实践建议：卒中后康复，恢复和社区参与-part1

加拿大心脏与卒中基金会(HSFC,Heart and Stroke Foundation of Canada) · 2020-01-27

2019 卒中肺炎工作组共识：卒中并发肺炎的抗生素治疗

国外神经内科相关专家小组（统称） · 2019-12-04

中国脑血管病临床管理指南（节选版）——卒中康复管理

中国卒中学会 · 2019-08-30

2019 NICE指南：大于16岁人群卒中和短暂性脑缺血发作的诊断和初期管理（NG.128）

暂未更新 · 2019-05-01

拓展阅读

2014 ACC/AHA非心脏手术患者围术期心血管的评估和管理指南

美国心脏病学会(ACC,American College of Cardiology) · 2014-08-01

2015 ACFAS临床共识声明：清洁择期足部手术围术期预防性抗生素的应用

美国足踝外科医师协会(ACFAS,American College of Foot and Ankle Surgeons) · 2015-01-24

围术期过敏反应诊治的专家共识

中华医学会麻醉学分会 · 2016-04-27

OSA患者围术期管理的专家共识

中华医学会麻醉学分会 · 2016-04-27

2016 ERAS建议：肝脏手术围术期护理指南

促进术后恢复学会(ERAS,The Enhanced Recovery After Surgery Society) · 2016-08-22

2016 围术期高血压管理专家共识

中国心胸血管麻醉学会 · 2016-03-30